{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:53:31Z","timestamp":1792752811396,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ando.2025.101691","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:23:34Z","timestamp":1736871814000},"page":"101691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chapter 2: Primary Hyperparathyroidism: diagnosis"],"prefix":"10.1016","volume":"86","author":[{"given":"Benjamin","family":"Bouillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Bertocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Nomin\u00e9-Criqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Kerlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101691_bib0350","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101691_bib0355","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0360","doi-asserted-by":"crossref","first-page":"101514","DOI":"10.1016\/j.berh.2020.101514","article-title":"Primary hyperparathyroidism","volume":"34","author":"Oberger Marques","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ando.2025.101691_bib0365","doi-asserted-by":"crossref","first-page":"7617254","DOI":"10.1155\/2019\/7617254","article-title":"Symptomatic hypercalcemia in patients with primary hyperparathyroidism is associated with severity of disease, polypharmacy, and comorbidity","volume":"2019","author":"Aresta","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ando.2025.101691_bib0370","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0375","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.3748\/wjg.v17.i36.4063","article-title":"Digestive manifestations of parathyroid disorders","volume":"17","author":"Abboud","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ando.2025.101691_bib0380","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0385","first-page":"279","article-title":"Effect of gender, biochemical parameters & parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism","volume":"139","author":"Shah","year":"2014","journal-title":"Indian J Med Re"},{"key":"10.1016\/j.ando.2025.101691_bib0390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.17219\/acem\/42626","article-title":"Interdisciplinary aspects of primary hyperparathyroidism: symptomatology in a series of 100 cases","volume":"25","author":"Jodkowska","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.ando.2025.101691_bib0395","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jocd.2018.06.005","article-title":"Usefulness of Trabecular Bone Score (TBS) to identify bone fragility in patients with primary hyperparathyroidism","volume":"22","author":"Mu\u00f1oz-Torres","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.ando.2025.101691_bib0400","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1210\/jc.2008-1965","article-title":"Acute pancreatitis in primary hyperparathyroidism: a population-based study","volume":"94","author":"Khoo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0405","first-page":"e60965","article-title":"Clinical, biochemical and surgical outcomes of primary hyperparathyroidism in the present era: a prospective study from a tertiary care hospital","volume":"16","author":"Misgar","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2025.101691_bib0410","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.11.080","article-title":"Primary hyperparathyroidism predicts hypertension: results from the National Inpatient Sample","volume":"227","author":"Kalla","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ando.2025.101691_bib0415","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1210\/jc.2013-4273","article-title":"Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism","volume":"99","author":"Stamatelopoulos","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0420","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0000000000001004","article-title":"Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial","volume":"34","author":"Verheyen","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2025.101691_bib0425","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.HYP.4.3.452","article-title":"Sympathetic system function and vascular reactivity in hypercalcemic patients","volume":"4","author":"Vlachakis","year":"1982","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2025.101691_bib0430","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0043-118347","article-title":"Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study","volume":"49","author":"Storvall","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2025.101691_bib0435","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1210\/jc.2018-02456","article-title":"Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: a randomized clinical trial","volume":"104","author":"Ejlsmark-Svensson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0440","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the City of Recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2025.101691_bib0450","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1007\/s10067-016-3450-3","article-title":"Musculoskeletal manifestations of primary hyperparathyroidism","volume":"35","author":"Pappu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ando.2025.101691_bib0455","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1530\/EC-18-0195","article-title":"Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single center's experience","volume":"7","author":"Reid","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2025.101691_bib0460","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00774-018-0922-3","article-title":"The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients","volume":"37","author":"Yao","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0465","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4158\/EP-2018-0268","article-title":"Primary hyperparathyroidism in the young: comparison with adult primary hyperparathyroidism","volume":"24","author":"Mukherjee","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2025.101691_bib0470","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40618-015-0423-3","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms","volume":"39","author":"Trombetti","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2025.101691_bib0475","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00268-009-9987-4","article-title":"What symptom improvement can be expected after operation for primary hyperparathyroidism?","volume":"33","author":"Caron","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2025.101691_bib0480","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/14737167.2014.873702","article-title":"Quality of life in patients with primary hyperparathyroidism","volume":"14","author":"Cipriani","year":"2014","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.ando.2025.101691_bib0485","first-page":"105","article-title":"Primary hyperparathyroidism in developing world: a systematic review on the changing clinical profile of the disease","volume":"64","author":"Yadav","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0490","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/cen.14045","article-title":"Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism","volume":"91","author":"Kearns","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101691_bib0495","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0500","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0505","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.4199","article-title":"Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study)","volume":"36","author":"Pretorius","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101691_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ando.2022.08.003","article-title":"Quality of life, mood and sleep quality in patients with primary hyperparathyroidism. Impact of socio-personal and clinical profile","volume":"84","author":"Febrero","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101691_bib0515","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jss.2018.07.028","article-title":"Timely evaluation and management of primary hyperparathyroidism in patients with kidney stones","volume":"232","author":"Perez","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.ando.2025.101691_bib0520","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.surg.2018.04.088","article-title":"End-organ effects of primary hyperparathyroidism: a population-based study","volume":"165","author":"Assadipour","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101691_bib0525","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamasurg.2020.2423","article-title":"Analysis of primary hyperparathyroidism screening among US veterans with kidney stones","volume":"155","author":"Ganesan","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ando.2025.101691_bib0530","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s11255-020-02476-0","article-title":"Screening for primary hyperparathyroidism in a tertiary stone clinic, a useful endeavor","volume":"52","author":"Boyd","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ando.2025.101691_bib0535","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jc.2018-00923","article-title":"Predictors of renal function and calcifications in primary hyperparathyroidism: a nested case-control study","volume":"103","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0540","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cen.14311","article-title":"A detailed appraisal of renal manifestations in primary hyperparathyroidism from Indian PHPT registry: before and after curative parathyroidectomy","volume":"94","author":"Agrawal","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101691_bib0545","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/ijem.IJEM_558_18","article-title":"A comparison between silent and symptomatic renal stones in primary hyperparathyroidism","volume":"23","author":"Misgar","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0550","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12020-017-1414-2","article-title":"Osteitis fibrosa cystica\u00a0\u2013\u00a0a forgotten radiological feature of primary hyperparathyroidism","volume":"58","author":"Misiorowski","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101691_bib0555","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s10067-016-3172-6","article-title":"Evaluation of acute and chronic MRI features of sacroiliitis in asymptomatic primary hyperparathyroid patients","volume":"35","author":"Tezcan","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ando.2025.101691_bib0560","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/rheumatology\/kep081","article-title":"An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease","volume":"48","author":"Richette","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ando.2025.101691_bib0565","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10067-014-2735-7","article-title":"Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients","volume":"34","author":"Ferrari","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ando.2025.101691_bib0570","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101691_bib0575","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.beem.2018.09.004","article-title":"Primary hyperparathyroidism","volume":"32","author":"Silva","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0580","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1681\/ASN.V12suppl_1s3","article-title":"Hypercalcemic crisis","volume":"12","author":"Ziegler","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2025.101691_bib0585","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ando.2024.01.012","article-title":"Acute hypercalcemic crisis: a narrative review with a focus on pregnancy","volume":"85","author":"Sabbah","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2025.101691_bib0590","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0595","doi-asserted-by":"crossref","first-page":"L27","DOI":"10.1210\/jc.2014-4065","article-title":"Letter to the editor: Thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism","volume":"100","author":"Yacobi-Bach","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0600","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MED.0000000000000198","article-title":"An overview of normocalcemic primary hyperparathyroidism","volume":"22","author":"Pawlowska","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ando.2025.101691_bib0605","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1515\/cclm-2019-0568","article-title":"Calcium state estimation by total calcium: the evidence to end the never-ending story","volume":"58","author":"Pekar","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ando.2025.101691_bib0610","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ando.2025.101691_bib0615","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/er.2018-00220","article-title":"Clinical guidelines and PTH measurement: does assay generation matter?","volume":"40","author":"Smit","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2025.101691_bib0620","doi-asserted-by":"crossref","first-page":"103","DOI":"10.33176\/AACB-20-00006","article-title":"Vitamin D metabolism and guidelines for vitamin D supplementation","volume":"41","author":"Ramasamy","year":"2020","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.ando.2025.101691_bib0625","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/EJE-15-0595","article-title":"Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients","volume":"174","author":"Souberbielle","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101691_bib0630","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2025.101691_bib0635","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-physiol-021113-170336","article-title":"Mechanisms and regulation of renal magnesium transport","volume":"76","author":"Houillier","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ando.2025.101691_bib0640","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM197503062921002","article-title":"A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias","volume":"292","author":"Pak","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2025.101691_bib0645","doi-asserted-by":"crossref","first-page":"h2723","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","volume":"350","author":"Minisola","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2025.101691_bib0650","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0655","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40618-019-01025-6","article-title":"Reliability of calcium-phosphorus (Ca\/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders","volume":"42","author":"Madeo","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2025.101691_bib0660","series-title":"StatPearls [Internet]","article-title":"Hypercalciuria","author":"Leslie","year":"2024"},{"key":"10.1016\/j.ando.2025.101691_bib0665","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101691_bib0670","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjsurg.2023.04.004","article-title":"Normohormonal primary hyperparathyroidism: a systematic review and meta-analysis","volume":"226","author":"Nabata","year":"2023","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2025.101691_bib0675","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European Expert Consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101691_bib0685","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101691_bib0690","unstructured":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)\u00a0\u2013\u00a0PubMed [Internet]. [cited 2024 May 26. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr\/30675420\/]."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:10:26Z","timestamp":1740514226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426625000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0003426625000101"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101691","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chapter 2: Primary Hyperparathyroidism: diagnosis","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101691"}}